Literature DB >> 23199929

The problem of colliding networks and its relation to cell fusion and cancer.

Alexei A Koulakov1, Yuri Lazebnik.   

Abstract

Cell fusion, a process that merges two or more cells into one, is required for normal development and has been explored as a tool for stem cell therapy. It has also been proposed that cell fusion causes cancer and contributes to its progression. These functions rely on a poorly understood ability of cell fusion to create new cell types. We suggest that this ability can be understood by considering cells as attractor networks whose basic property is to adopt a set of distinct, stable, self-maintaining states called attractors. According to this view, fusion of two cell types is a collision of two networks that have adopted distinct attractors. To learn how these networks reach a consensus, we model cell fusion computationally. To do so, we simulate patterns of gene activities using a formalism developed to simulate patterns of memory in neural networks. We find that the hybrid networks can assume attractors that are unrelated to parental attractors, implying that cell fusion can create new cell types by nearly instantaneously moving cells between attractors. We also show that hybrid networks are prone to assume spurious attractors, which are emergent and sporadic network states. This finding means that cell fusion can produce abnormal cell types, including cancerous types, by placing cells into normally inaccessible spurious states. Finally, we suggest that the problem of colliding networks has general significance in many processes represented by attractor networks, including biological, social, and political phenomena.
Copyright © 2012 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23199929      PMCID: PMC3491708          DOI: 10.1016/j.bpj.2012.08.062

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  54 in total

1.  Emergence of scaling in random networks

Authors: 
Journal:  Science       Date:  1999-10-15       Impact factor: 47.728

Review 2.  Insights into viral transmission at the uterine-placental interface.

Authors:  Lenore Pereira; Ekaterina Maidji; Susan McDonagh; Takako Tabata
Journal:  Trends Microbiol       Date:  2005-04       Impact factor: 17.079

Review 3.  Opinion: the origin of the cancer stem cell: current controversies and new insights.

Authors:  Rolf Bjerkvig; Berit B Tysnes; Karen S Aboody; Joseph Najbauer; A J A Terzis
Journal:  Nat Rev Cancer       Date:  2005-11       Impact factor: 60.716

4.  Nuclear reprogramming in heterokaryons is rapid, extensive, and bidirectional.

Authors:  Adam Palermo; Regis Doyonnas; Nidhi Bhutani; Jason Pomerantz; Ozan Alkan; Helen M Blau
Journal:  FASEB J       Date:  2009-01-13       Impact factor: 5.191

Review 5.  Cell fusion as a hidden force in tumor progression.

Authors:  Xin Lu; Yibin Kang
Journal:  Cancer Res       Date:  2009-11-03       Impact factor: 12.701

6.  Diagnosing endometrial hyperplasia: why is it so difficult to agree?

Authors:  Kimberly H Allison; Susan D Reed; Lynda F Voigt; Carolyn D Jordan; Kathryn M Newton; Rochelle L Garcia
Journal:  Am J Surg Pathol       Date:  2008-05       Impact factor: 6.394

Review 7.  Tumor heterogeneity: causes and consequences.

Authors:  Andriy Marusyk; Kornelia Polyak
Journal:  Biochim Biophys Acta       Date:  2009-11-18

Review 8.  Systems biology of stem cell fate and cellular reprogramming.

Authors:  Ben D Macarthur; Avi Ma'ayan; Ihor R Lemischka
Journal:  Nat Rev Mol Cell Biol       Date:  2009-09-09       Impact factor: 94.444

9.  HIV-infected T cells are migratory vehicles for viral dissemination.

Authors:  Thomas T Murooka; Maud Deruaz; Francesco Marangoni; Vladimir D Vrbanac; Edward Seung; Ulrich H von Andrian; Andrew M Tager; Andrew D Luster; Thorsten R Mempel
Journal:  Nature       Date:  2012-08-01       Impact factor: 49.962

Review 10.  Viral and developmental cell fusion mechanisms: conservation and divergence.

Authors:  Amir Sapir; Ori Avinoam; Benjamin Podbilewicz; Leonid V Chernomordik
Journal:  Dev Cell       Date:  2008-01       Impact factor: 12.270

View more
  8 in total

1.  Are scientists a workforce? - Or, how Dr. Frankenstein made biomedical research sick: A proposed plan to rescue US biomedical research from its current 'malaise' will not be effective as it misdiagnoses the root cause of the disease.

Authors:  Yuri Lazebnik
Journal:  EMBO Rep       Date:  2015-11-13       Impact factor: 8.807

2.  The shock of being united and symphiliosis. Another lesson from plants?

Authors:  Yuri Lazebnik
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

3.  Colliding dynamical complex network models: biological attractors versus attractors from material physics.

Authors:  Avi Ma'ayan
Journal:  Biophys J       Date:  2012-11-07       Impact factor: 4.033

Review 4.  Generation of Cancer Stem/Initiating Cells by Cell-Cell Fusion.

Authors:  Thomas Dittmar
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

Review 5.  Interneuron Types as Attractors and Controllers.

Authors:  Gord Fishell; Adam Kepecs
Journal:  Annu Rev Neurosci       Date:  2019-07-12       Impact factor: 15.553

6.  Spontaneous cell fusions as a mechanism of parasexual recombination in tumour cell populations.

Authors:  Daria Miroshnychenko; Etienne Baratchart; David Basanta; Andriy Marusyk; Meghan C Ferrall-Fairbanks; Robert Vander Velde; Mark A Laurie; Marilyn M Bui; Aik Choon Tan; Philipp M Altrock
Journal:  Nat Ecol Evol       Date:  2021-01-18       Impact factor: 19.100

7.  Cell fusion as a link between the SARS-CoV-2 spike protein, COVID-19 complications, and vaccine side effects.

Authors:  Yuri Lazebnik
Journal:  Oncotarget       Date:  2021-12-07

8.  Not just a colourful metaphor: modelling the landscape of cellular development using Hopfield networks.

Authors:  Atefeh Taherian Fard; Sriganesh Srihari; Jessica C Mar; Mark A Ragan
Journal:  NPJ Syst Biol Appl       Date:  2016-02-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.